Loading…

Identification of Methylation Signatures and Rules for Sarcoma Subtypes by Machine Learning Methods

Sarcoma, the second common type of solid tumor in children and adolescents, has a wide variety of subtypes that are often not properly diagnosed at an early stage, leading to late metastases and causing serious loss of life and property to patients and families. It exhibits a high degree of heteroge...

Full description

Saved in:
Bibliographic Details
Published in:BioMed research international 2022-12, Vol.2022, p.5297235-11
Main Authors: Ren, Jingxin, Zhou, XianChao, Guo, Wei, Feng, KaiYan, Huang, Tao, Cai, Yu-Dong
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c476t-ba8e0248692319f18b14f553077517e3f560232970a1421988def32d61ded2013
cites cdi_FETCH-LOGICAL-c476t-ba8e0248692319f18b14f553077517e3f560232970a1421988def32d61ded2013
container_end_page 11
container_issue
container_start_page 5297235
container_title BioMed research international
container_volume 2022
creator Ren, Jingxin
Zhou, XianChao
Guo, Wei
Feng, KaiYan
Huang, Tao
Cai, Yu-Dong
description Sarcoma, the second common type of solid tumor in children and adolescents, has a wide variety of subtypes that are often not properly diagnosed at an early stage, leading to late metastases and causing serious loss of life and property to patients and families. It exhibits a high degree of heterogeneity at the cellular, molecular, and epigenetic levels, where DNA methylation has been proposed to play a role in the diagnosis of sarcoma subtypes. Thus, this study is aimed at finding potential biomarkers at the DNA methylation level to distinguish different sarcoma subtypes. A machine learning process was designed to analyse sarcoma samples, each of which was represented by lots of methylation sites. Irrelevant sites were removed using the Boruta method, and remaining sites related to the target variables were kept for further analyses. Afterward, three feature ranking methods (LASSO, LightGBM, and MCFS) were adopted to rank these features, and six classification models were constructed by combining incremental feature selection and two classification algorithms (decision tree and random forest). Among these models, the performance of RF model was higher than that of DT model under all three ranking conditions. The specific expression of genes obtained from the annotation of highly correlated methylation site features, such as PRKAR1B, INPP5A, and GLI3, was proven to be associated with sarcoma by publications. Moreover, the quantitative rules obtained by decision tree algorithm helped us to understand the essential differences between various sarcoma types and classify sarcoma subtypes, providing a new means of clinical identification and determining new therapeutic targets.
doi_str_mv 10.1155/2022/5297235
format article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9812612</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A732625484</galeid><sourcerecordid>A732625484</sourcerecordid><originalsourceid>FETCH-LOGICAL-c476t-ba8e0248692319f18b14f553077517e3f560232970a1421988def32d61ded2013</originalsourceid><addsrcrecordid>eNp9kUuLFDEUhYMozjDOzrUUuBG0ndyk8qiNMAw-BnoQbF2HVB7dGaqTNqlS-t-bstv2sTCbe3PzcXIPB6GngF8DMHZFMCFXjHSCUPYAnRMK7YJDCw9PPaVn6LKUe1yPBI47_hidUc6ho5ifI3NrXRyDD0aPIcUm-ebOjZv9cLiuwjrqccquNDra5tM01M6n3Kx0Nmmrm9XUj_tdHfb75k6bTYiuWTqdY4jrn0rJlifokddDcZfHeoG-vHv7-ebDYvnx_e3N9XJhWsHHRa-lw6SVvKurdx5kD61njGIhGAhHPeOY0OoVa2gJdFJa5ymxHKyzBAO9QG8Ourup3zprqrGsB7XLYavzXiUd1N8vMWzUOn1TnQTCgVSBF0eBnL5OroxqG4pxw6CjS1NRRHAiCTA8o8__Qe_TlGO1N1MghOgk-02t9eBUiD7Vf80sqq4FJZywVraVenWgTE6lZOdPKwNWc8xqjlkdY674sz9tnuBfoVbg5QGoaVj9Pfxf7gfasa0b</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2761777985</pqid></control><display><type>article</type><title>Identification of Methylation Signatures and Rules for Sarcoma Subtypes by Machine Learning Methods</title><source>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</source><source>Wiley Online Library Journals Open Access</source><creator>Ren, Jingxin ; Zhou, XianChao ; Guo, Wei ; Feng, KaiYan ; Huang, Tao ; Cai, Yu-Dong</creator><contributor>Kim, Kwang Gi ; Kwang Gi Kim</contributor><creatorcontrib>Ren, Jingxin ; Zhou, XianChao ; Guo, Wei ; Feng, KaiYan ; Huang, Tao ; Cai, Yu-Dong ; Kim, Kwang Gi ; Kwang Gi Kim</creatorcontrib><description>Sarcoma, the second common type of solid tumor in children and adolescents, has a wide variety of subtypes that are often not properly diagnosed at an early stage, leading to late metastases and causing serious loss of life and property to patients and families. It exhibits a high degree of heterogeneity at the cellular, molecular, and epigenetic levels, where DNA methylation has been proposed to play a role in the diagnosis of sarcoma subtypes. Thus, this study is aimed at finding potential biomarkers at the DNA methylation level to distinguish different sarcoma subtypes. A machine learning process was designed to analyse sarcoma samples, each of which was represented by lots of methylation sites. Irrelevant sites were removed using the Boruta method, and remaining sites related to the target variables were kept for further analyses. Afterward, three feature ranking methods (LASSO, LightGBM, and MCFS) were adopted to rank these features, and six classification models were constructed by combining incremental feature selection and two classification algorithms (decision tree and random forest). Among these models, the performance of RF model was higher than that of DT model under all three ranking conditions. The specific expression of genes obtained from the annotation of highly correlated methylation site features, such as PRKAR1B, INPP5A, and GLI3, was proven to be associated with sarcoma by publications. Moreover, the quantitative rules obtained by decision tree algorithm helped us to understand the essential differences between various sarcoma types and classify sarcoma subtypes, providing a new means of clinical identification and determining new therapeutic targets.</description><identifier>ISSN: 2314-6133</identifier><identifier>ISSN: 2314-6141</identifier><identifier>EISSN: 2314-6141</identifier><identifier>DOI: 10.1155/2022/5297235</identifier><identifier>PMID: 36619306</identifier><language>eng</language><publisher>United States: Hindawi</publisher><subject>Accuracy ; Adolescent ; Algorithms ; Annotations ; Biomarkers ; Cancer ; Chemical properties ; Child ; Classification ; Datasets ; Decision trees ; Deoxyribonucleic acid ; Diagnosis ; DNA ; DNA methylation ; DNA Methylation - genetics ; Epigenetics ; Ewings sarcoma ; Feature selection ; Gene expression ; Genetic aspects ; Health aspects ; Heterogeneity ; Humans ; Learning algorithms ; Machine Learning ; Medical diagnosis ; Metastases ; Methylation ; Oncology, Experimental ; Ranking ; Sarcoma ; Sarcoma - diagnosis ; Sarcoma - genetics ; Soft Tissue Neoplasms ; Solid tumors ; Therapeutic targets ; Tumors</subject><ispartof>BioMed research international, 2022-12, Vol.2022, p.5297235-11</ispartof><rights>Copyright © 2022 Jingxin Ren et al.</rights><rights>COPYRIGHT 2022 John Wiley &amp; Sons, Inc.</rights><rights>Copyright © 2022 Jingxin Ren et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. https://creativecommons.org/licenses/by/4.0</rights><rights>Copyright © 2022 Jingxin Ren et al. 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c476t-ba8e0248692319f18b14f553077517e3f560232970a1421988def32d61ded2013</citedby><cites>FETCH-LOGICAL-c476t-ba8e0248692319f18b14f553077517e3f560232970a1421988def32d61ded2013</cites><orcidid>0000-0003-1975-9693 ; 0000-0001-5664-7979</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2761777985/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2761777985?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,780,784,885,25753,27924,27925,37012,37013,44590,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36619306$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Kim, Kwang Gi</contributor><contributor>Kwang Gi Kim</contributor><creatorcontrib>Ren, Jingxin</creatorcontrib><creatorcontrib>Zhou, XianChao</creatorcontrib><creatorcontrib>Guo, Wei</creatorcontrib><creatorcontrib>Feng, KaiYan</creatorcontrib><creatorcontrib>Huang, Tao</creatorcontrib><creatorcontrib>Cai, Yu-Dong</creatorcontrib><title>Identification of Methylation Signatures and Rules for Sarcoma Subtypes by Machine Learning Methods</title><title>BioMed research international</title><addtitle>Biomed Res Int</addtitle><description>Sarcoma, the second common type of solid tumor in children and adolescents, has a wide variety of subtypes that are often not properly diagnosed at an early stage, leading to late metastases and causing serious loss of life and property to patients and families. It exhibits a high degree of heterogeneity at the cellular, molecular, and epigenetic levels, where DNA methylation has been proposed to play a role in the diagnosis of sarcoma subtypes. Thus, this study is aimed at finding potential biomarkers at the DNA methylation level to distinguish different sarcoma subtypes. A machine learning process was designed to analyse sarcoma samples, each of which was represented by lots of methylation sites. Irrelevant sites were removed using the Boruta method, and remaining sites related to the target variables were kept for further analyses. Afterward, three feature ranking methods (LASSO, LightGBM, and MCFS) were adopted to rank these features, and six classification models were constructed by combining incremental feature selection and two classification algorithms (decision tree and random forest). Among these models, the performance of RF model was higher than that of DT model under all three ranking conditions. The specific expression of genes obtained from the annotation of highly correlated methylation site features, such as PRKAR1B, INPP5A, and GLI3, was proven to be associated with sarcoma by publications. Moreover, the quantitative rules obtained by decision tree algorithm helped us to understand the essential differences between various sarcoma types and classify sarcoma subtypes, providing a new means of clinical identification and determining new therapeutic targets.</description><subject>Accuracy</subject><subject>Adolescent</subject><subject>Algorithms</subject><subject>Annotations</subject><subject>Biomarkers</subject><subject>Cancer</subject><subject>Chemical properties</subject><subject>Child</subject><subject>Classification</subject><subject>Datasets</subject><subject>Decision trees</subject><subject>Deoxyribonucleic acid</subject><subject>Diagnosis</subject><subject>DNA</subject><subject>DNA methylation</subject><subject>DNA Methylation - genetics</subject><subject>Epigenetics</subject><subject>Ewings sarcoma</subject><subject>Feature selection</subject><subject>Gene expression</subject><subject>Genetic aspects</subject><subject>Health aspects</subject><subject>Heterogeneity</subject><subject>Humans</subject><subject>Learning algorithms</subject><subject>Machine Learning</subject><subject>Medical diagnosis</subject><subject>Metastases</subject><subject>Methylation</subject><subject>Oncology, Experimental</subject><subject>Ranking</subject><subject>Sarcoma</subject><subject>Sarcoma - diagnosis</subject><subject>Sarcoma - genetics</subject><subject>Soft Tissue Neoplasms</subject><subject>Solid tumors</subject><subject>Therapeutic targets</subject><subject>Tumors</subject><issn>2314-6133</issn><issn>2314-6141</issn><issn>2314-6141</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNp9kUuLFDEUhYMozjDOzrUUuBG0ndyk8qiNMAw-BnoQbF2HVB7dGaqTNqlS-t-bstv2sTCbe3PzcXIPB6GngF8DMHZFMCFXjHSCUPYAnRMK7YJDCw9PPaVn6LKUe1yPBI47_hidUc6ho5ifI3NrXRyDD0aPIcUm-ebOjZv9cLiuwjrqccquNDra5tM01M6n3Kx0Nmmrm9XUj_tdHfb75k6bTYiuWTqdY4jrn0rJlifokddDcZfHeoG-vHv7-ebDYvnx_e3N9XJhWsHHRa-lw6SVvKurdx5kD61njGIhGAhHPeOY0OoVa2gJdFJa5ymxHKyzBAO9QG8Ourup3zprqrGsB7XLYavzXiUd1N8vMWzUOn1TnQTCgVSBF0eBnL5OroxqG4pxw6CjS1NRRHAiCTA8o8__Qe_TlGO1N1MghOgk-02t9eBUiD7Vf80sqq4FJZywVraVenWgTE6lZOdPKwNWc8xqjlkdY674sz9tnuBfoVbg5QGoaVj9Pfxf7gfasa0b</recordid><startdate>20221228</startdate><enddate>20221228</enddate><creator>Ren, Jingxin</creator><creator>Zhou, XianChao</creator><creator>Guo, Wei</creator><creator>Feng, KaiYan</creator><creator>Huang, Tao</creator><creator>Cai, Yu-Dong</creator><general>Hindawi</general><general>John Wiley &amp; Sons, Inc</general><general>Hindawi Limited</general><scope>RHU</scope><scope>RHW</scope><scope>RHX</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7QO</scope><scope>7T7</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>CWDGH</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-1975-9693</orcidid><orcidid>https://orcid.org/0000-0001-5664-7979</orcidid></search><sort><creationdate>20221228</creationdate><title>Identification of Methylation Signatures and Rules for Sarcoma Subtypes by Machine Learning Methods</title><author>Ren, Jingxin ; Zhou, XianChao ; Guo, Wei ; Feng, KaiYan ; Huang, Tao ; Cai, Yu-Dong</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c476t-ba8e0248692319f18b14f553077517e3f560232970a1421988def32d61ded2013</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Accuracy</topic><topic>Adolescent</topic><topic>Algorithms</topic><topic>Annotations</topic><topic>Biomarkers</topic><topic>Cancer</topic><topic>Chemical properties</topic><topic>Child</topic><topic>Classification</topic><topic>Datasets</topic><topic>Decision trees</topic><topic>Deoxyribonucleic acid</topic><topic>Diagnosis</topic><topic>DNA</topic><topic>DNA methylation</topic><topic>DNA Methylation - genetics</topic><topic>Epigenetics</topic><topic>Ewings sarcoma</topic><topic>Feature selection</topic><topic>Gene expression</topic><topic>Genetic aspects</topic><topic>Health aspects</topic><topic>Heterogeneity</topic><topic>Humans</topic><topic>Learning algorithms</topic><topic>Machine Learning</topic><topic>Medical diagnosis</topic><topic>Metastases</topic><topic>Methylation</topic><topic>Oncology, Experimental</topic><topic>Ranking</topic><topic>Sarcoma</topic><topic>Sarcoma - diagnosis</topic><topic>Sarcoma - genetics</topic><topic>Soft Tissue Neoplasms</topic><topic>Solid tumors</topic><topic>Therapeutic targets</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ren, Jingxin</creatorcontrib><creatorcontrib>Zhou, XianChao</creatorcontrib><creatorcontrib>Guo, Wei</creatorcontrib><creatorcontrib>Feng, KaiYan</creatorcontrib><creatorcontrib>Huang, Tao</creatorcontrib><creatorcontrib>Cai, Yu-Dong</creatorcontrib><collection>Hindawi Publishing Complete</collection><collection>Hindawi Publishing Subscription Journals</collection><collection>Hindawi Publishing Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Middle East &amp; Africa Database</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>BioMed research international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ren, Jingxin</au><au>Zhou, XianChao</au><au>Guo, Wei</au><au>Feng, KaiYan</au><au>Huang, Tao</au><au>Cai, Yu-Dong</au><au>Kim, Kwang Gi</au><au>Kwang Gi Kim</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Identification of Methylation Signatures and Rules for Sarcoma Subtypes by Machine Learning Methods</atitle><jtitle>BioMed research international</jtitle><addtitle>Biomed Res Int</addtitle><date>2022-12-28</date><risdate>2022</risdate><volume>2022</volume><spage>5297235</spage><epage>11</epage><pages>5297235-11</pages><issn>2314-6133</issn><issn>2314-6141</issn><eissn>2314-6141</eissn><abstract>Sarcoma, the second common type of solid tumor in children and adolescents, has a wide variety of subtypes that are often not properly diagnosed at an early stage, leading to late metastases and causing serious loss of life and property to patients and families. It exhibits a high degree of heterogeneity at the cellular, molecular, and epigenetic levels, where DNA methylation has been proposed to play a role in the diagnosis of sarcoma subtypes. Thus, this study is aimed at finding potential biomarkers at the DNA methylation level to distinguish different sarcoma subtypes. A machine learning process was designed to analyse sarcoma samples, each of which was represented by lots of methylation sites. Irrelevant sites were removed using the Boruta method, and remaining sites related to the target variables were kept for further analyses. Afterward, three feature ranking methods (LASSO, LightGBM, and MCFS) were adopted to rank these features, and six classification models were constructed by combining incremental feature selection and two classification algorithms (decision tree and random forest). Among these models, the performance of RF model was higher than that of DT model under all three ranking conditions. The specific expression of genes obtained from the annotation of highly correlated methylation site features, such as PRKAR1B, INPP5A, and GLI3, was proven to be associated with sarcoma by publications. Moreover, the quantitative rules obtained by decision tree algorithm helped us to understand the essential differences between various sarcoma types and classify sarcoma subtypes, providing a new means of clinical identification and determining new therapeutic targets.</abstract><cop>United States</cop><pub>Hindawi</pub><pmid>36619306</pmid><doi>10.1155/2022/5297235</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0003-1975-9693</orcidid><orcidid>https://orcid.org/0000-0001-5664-7979</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2314-6133
ispartof BioMed research international, 2022-12, Vol.2022, p.5297235-11
issn 2314-6133
2314-6141
2314-6141
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9812612
source Publicly Available Content Database (Proquest) (PQ_SDU_P3); Wiley Online Library Journals Open Access
subjects Accuracy
Adolescent
Algorithms
Annotations
Biomarkers
Cancer
Chemical properties
Child
Classification
Datasets
Decision trees
Deoxyribonucleic acid
Diagnosis
DNA
DNA methylation
DNA Methylation - genetics
Epigenetics
Ewings sarcoma
Feature selection
Gene expression
Genetic aspects
Health aspects
Heterogeneity
Humans
Learning algorithms
Machine Learning
Medical diagnosis
Metastases
Methylation
Oncology, Experimental
Ranking
Sarcoma
Sarcoma - diagnosis
Sarcoma - genetics
Soft Tissue Neoplasms
Solid tumors
Therapeutic targets
Tumors
title Identification of Methylation Signatures and Rules for Sarcoma Subtypes by Machine Learning Methods
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T20%3A25%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Identification%20of%20Methylation%20Signatures%20and%20Rules%20for%20Sarcoma%20Subtypes%20by%20Machine%20Learning%20Methods&rft.jtitle=BioMed%20research%20international&rft.au=Ren,%20Jingxin&rft.date=2022-12-28&rft.volume=2022&rft.spage=5297235&rft.epage=11&rft.pages=5297235-11&rft.issn=2314-6133&rft.eissn=2314-6141&rft_id=info:doi/10.1155/2022/5297235&rft_dat=%3Cgale_pubme%3EA732625484%3C/gale_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c476t-ba8e0248692319f18b14f553077517e3f560232970a1421988def32d61ded2013%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2761777985&rft_id=info:pmid/36619306&rft_galeid=A732625484&rfr_iscdi=true